QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 38m ago

105last 24h

3127last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: SLSsentiment: neutralSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Stocktwits5d agoneutral

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts - Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

Stocktwits6d agoneutral

SLS Stock Hits Over 1-Month Low: Retail Bulls Double Down Before Cancer Data - Fresh Filings Show Q3 Stake Hikes Of Over 400%

Stocktwits11d agoneutral

SLS Stock Gets A BlackRock Spotlight Ahead Of Phase 3 AML Data - Bulls Spot 2027 European GPS Approval Forecast

Stocktwits44d agoneutral

SLS Stock Slips 3% As Pancreatic Cancer Lab Data Leave REGAL Wait Unanswered

Stocktwits45d agoneutral

SLS Stock Slips Overnight Ahead Of Pancreatic Cancer Conference - Retail Looks For Clues To SLS009’s Next Trial

Stocktwits55d agoneutral

SLS, IBRX, IOVA In Focus Amid Big Pharma’s Early Cancer-Asset Hunt: J&J Flags M&A ‘Sweet Spot,’ Pfizer Eyes Phase 1-2 Deals

IBRX IOVA JNJ PFE SLS

Stocktwits55d agoneutral

SLS, IBRX Stocks Draw Investor Attention With Major Cancer Conferences And New Drug Data On Deck

Stocktwits60d agoneutral

SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts

Stocktwits68d agoneutral

SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

Stocktwits70d agoneutral

SLS Stock Rises Overnight: Healthcare Execs Tout AML Drug As ‘Game Changer’ Ahead Of Final Trial Trigger

Stocktwits73d agoneutral

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future

IBRX MRK MRNA SLS

Stocktwits74d agoneutral

SLS, IBRX Catch The Eye Of A Major US Pension Fund - And Big Clinical Catalysts Are On The Horizon

Stocktwits76d agoneutral

SLS Traders Eye This Important Resistance Zone Ahead Of Key AML Data Readout

Stocktwits77d agoneutral

SLS Stock Charges Ahead As AML Trial Buzz Builds: Report Claims Regal Hit 80th Event - Retail Isn’t Convinced

Stocktwits79d agoneutral

SLS Stock Clocks Three Straight Weeks Of Gains On Cancer Vaccine Spillover, REGAL Trial Data Anticipation

Stocktwits80d agoneutral

SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology

IBRX MRK MRNA SLS

Stocktwits81d agoneutral

SLS Stock Edges Higher As Wall Street, Retail Expect Another MRNA Moment

Stocktwits83d agoneutral

Goldman Sachs Builds $75M Bet Across CAPR, SLS And IBRX As Major Catalysts Loom

Stocktwits87d agoneutral

SLS And IBRX Eye Green Weekly Close: Vanguard’s Major Stakes In Cancer Drugmakers Steal The Spotlight

Stocktwits89d agoneutral

SLS Stock Holds Steady After Q2 Update - Investors Eye End Of GPS Quiet Period

Stocktwits89d agoneutral

SLS Stock Rebounds Premarket After Worst Day In 3 Weeks - Retail Awaits ‘Very Special’ Earnings Update

Stocktwits95d agoneutral

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

AMGN IBRX MRK PFE SLS

Stocktwits97d agoneutral

SLS Stock Logs Best Day In Over 2 Weeks: Citigroup Builds Nearly $5M Stake Ahead Of Key AML Trial Trigger

Stocktwits100d agoneutral

SLS Stock In Spotlight After Vanguard Capital Discloses 5.19% Stake - Retail Calls It ‘Huge Vote Of Conviction’ As AML Trial Readout Nears

Stocktwits101d agoneutral

SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger

Stocktwits103d agoneutral

SLS Stock Hits 1-Month Low On China Arbitration Blow - Retail Bulls Call It A ‘Nothingburger’ Ahead Of AML Readout

Stocktwits104d agoneutral

SLS Stock Climbs Premarket: Here’s What Smart Money Is Doing As Sellas Nears Critical Phase 3 AML Readout

Stocktwits107d agoneutral

Sellas CEO Angelos Stergiou Says ‘100% Certain’ AI Can Be Used To Beat Cancer

Stocktwits107d agoneutral

SLS Stock Rises Overnight: Retail Traders Call New AML Survival Data 'Huge' Ahead Of CEO’s Fox Appearance

Stocktwits108d agoneutral

SLS Stock July Rout Deepens: ‘Pharma Bro’ Martin Shkreli Questions Timing Of AML Trial, Says Data May Wait Until Christmas